Genzyme Corporation is one of the foremost biotechnological companies in the world today. Genzyme Corporation was established in Boston during 1981 and since then it has developed to the diversified enterprise achieving an annual revenues over 3 billion USD with the help of company’s work forces of over 9,500 heads working in different countries all over the world. They are integrated by a common goal of making the significant affirmative crash on the lives of people with unbearable ailments. Genzyme Corporation was selected by FORTUNE as one of the 100 best companies worth working with in the US during 2006-07.

Genzyme Corporation is the forerunner in the endurance of developing and applying most modern technologies in the fields of life sciences through several recognized products and services helping patients in almost 90 different countries across the globe today. The major products of the company chiefly focus on exceptionally hereditary ailments, kidney diseases, orthopedics, transplantation, cancer as well as various diagnostic testing. The company is dedicated to consistent advancements through the extensive research and development programs highlighting such sectors in addition to the immune disorders, contagious diseases and other sectors of deprived medical necessities.   

Genzyme maintains its drive towards its commitments to the patients and is working for developing medications, enhance its current therapies, obtain clearances for the new products all over the world and make certain that patients are given such treatments. The company is presently concentrating on its wide-ranging medication products like: Cerezyme, Ceredase, Febrazyme, Aldurazyme, Myozyme, MTAP – the Myozyme, Renagel, Hectorol, Synvisc, Carticel, Thymoglobulin, Campath, Clolar, Thyrogen and so on.